In support of these observations, PDXK, the enzyme that converts pyridoxine into PLP (see above), has been identified as upregulated in non-small cell lung carcinoma (NSCLC) and therefore resembles a therapy-independent prognostic marker in patients with NSCLC.34 Here, PDXK is linked to non-small cell lung carcinoma.